Inventor · disambiguated record
Haihui Lu
Also filed as: LU HAIHUI
3 granted patents·9 pending applications·14 citations·filing 2016–2024
66Inventor score
Top patents by PatentIndex Score
12 records- 0193US12275795B2Binding molecules against BCMA and uses thereofNOVARTIS AG·Filed 2022·Granted Apr 15, 2025·2 cites·23 claims
- 0293US11492409B2Binding molecules against BCMA and uses thereofNOVARTIS AG·Filed 2019·Granted Nov 8, 2022·10 cites·26 claims
- 0384US12221481B2CD19 binding molecules and uses thereofNOVARTIS AG·Filed 2020·Granted Feb 11, 2025·2 cites·13 claims
- 0470US2025223359A1Cd19 binding molecules and uses thereofNOVARTIS AG·Filed 2024·Application pending·0 cites
- 0563US2025340634A1Dosage regimens for anti-cd19 agents and uses thereofNOVARTIS AG·Filed 2023·Application pending·0 cites
- 0653US2025215081A1Anti-cd19 agent and b cell targeting agent combination therapy for treating b cell malignanciesNOVARTIS AG·Filed 2021·Application pending·0 cites
- 0750US2022332821A1Dosing regimen and combination therapies for multispecific antibodies targeting b-cell maturation antigenNOVARTIS AG·Filed 2020·Application pending·0 cites
- 0850US2024025993A1Cd19 binding molecules and uses thereofNOVARTIS AG·Filed 2021·Application pending·0 cites
- 0948US2022396631A1Trispecific binding molecules against bcma and uses thereofHUANG LU·Filed 2020·Application pending·0 cites
- 1047US2020179511A1Bcma-targeting agent, and combination therapy with a gamma secretase inhibitorDALEY MICHAEL·Filed 2018·Application pending·0 cites
- 1138US2021040205A1Antibodies targeting cd32b and methods of use thereofNOVARTIS AG·Filed 2018·Application pending·0 cites
- 1236US2017198040A1ANTIBODIES TARGETING CD32b AND METHODS OF USE THEREOFNOVARTIS AG·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Haihui Lu files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →